Skip to main content

Table 4 Costs and benefits from provider perspective and societal perspective

From: Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea

 

Perspective

Costs per 1000 travellers

Provider

Societal

Vaccination (Vaccine+IVC)

57,210.00

57,210.00

Disease without vaccination

26,931.30

214,637.01

Disease with vaccination

57,889.42

135,356.56

Net saving

-30,958.12

79,280.45

Benefit-cost ratio

-

1.39